{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Minneapolis&page=40&state=Minnesota", "query": { "state": "Minnesota", "city": "Minneapolis", "page": 40 }, "page_size": 10 }, "pagination": { "page": 40, "page_size": 10, "total_count": 7866, "total_pages": 787, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Minneapolis&page=41&state=Minnesota&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Minneapolis&page=39&state=Minnesota&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-09T22:26:03.735Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00386100", "title": "A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Avandamet 6 mg/1500 mg (ttd)", "type": "DRUG" }, { "name": "Avandamet 4 mg/1000 mg (ttd)", "type": "DRUG" }, { "name": "Avandamet 2 mg/500 mg (ttd)", "type": "DRUG" }, { "name": "Avandamet 8 mg/ 2000 mg (ttd)", "type": "DRUG" }, { "name": "Metformin 500 mg (ttd)", "type": "DRUG" }, { "name": "Metformin 1000 mg (ttd)", "type": "DRUG" }, { "name": "Metformin 1500 mg (ttd)", "type": "DRUG" }, { "name": "Metformin 2000 mg (ttd)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 688, "start_date": "2006-10", "completion_date": "2009-09", "has_results": true, "last_update_posted_date": "2016-11-23", "last_synced_at": "2026-11-09T22:26:03.735Z", "location_count": 71, "location_summary": "Tuscaloosa, Alabama • Gilbert, Arizona • Glendale, Arizona + 65 more", "locations": [ { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00386100" }, { "nct_id": "NCT06531109", "title": "Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Alopecia Areata" ], "interventions": [ { "name": "Ritlecitinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 450, "start_date": "2024-08-07", "completion_date": "2028-04-15", "has_results": false, "last_update_posted_date": "2026-11-06", "last_synced_at": "2026-11-09T22:26:03.735Z", "location_count": 28, "location_summary": "Birmingham, Alabama • Montgomery, Alabama • Fremont, California + 23 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Fremont", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Oxnard", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06531109" }, { "nct_id": "NCT03728699", "title": "Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Acute Myeloid Leukemia" ], "interventions": [ { "name": "Sample Collection Blood", "type": "DIAGNOSTIC_TEST" }, { "name": "Stool Sample", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Masonic Cancer Center, University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 54, "start_date": "2018-01-02", "completion_date": "2022-02-18", "has_results": false, "last_update_posted_date": "2023-11-03", "last_synced_at": "2026-11-09T22:26:03.735Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03728699" }, { "nct_id": "NCT06767514", "title": "Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Non-Small Cell Lung Cancer" ], "interventions": [ { "name": "Ivonescimab Injection", "type": "BIOLOGICAL" }, { "name": "Pembrolizumab Injection", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Summit Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 780, "start_date": "2025-02-27", "completion_date": "2029-06", "has_results": false, "last_update_posted_date": "2026-09-18", "last_synced_at": "2026-11-09T22:26:03.735Z", "location_count": 97, "location_summary": "Chandler, Arizona • Phoenix, Arizona • Hot Springs, Arkansas + 86 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Alameda", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06767514" }, { "nct_id": "NCT00036218", "title": "Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Parkinson Disease" ], "interventions": [ { "name": "sumanirole", "type": "DRUG" }, { "name": "ropinirole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 600, "start_date": "2001-12", "completion_date": "2003-04", "has_results": false, "last_update_posted_date": "2006-06-07", "last_synced_at": "2026-11-09T22:26:03.735Z", "location_count": 93, "location_summary": "Hot Springs, Arkansas • Little Rock, Arkansas • Carmichael, California + 81 more", "locations": [ { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Carmichael", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Irvine", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00036218" }, { "nct_id": "NCT06363760", "title": "A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Sickle Cell Disease", "Transfusion-dependent Beta-Thalassemia", "Hemoglobinopathies" ], "interventions": [ { "name": "Safety and efficacy assessments", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Editas Medicine, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "12 Years to 50 Years" }, "enrollment_count": 54, "start_date": "2024-06-17", "completion_date": "2040-08", "has_results": false, "last_update_posted_date": "2025-04-02", "last_synced_at": "2026-11-09T22:26:03.735Z", "location_count": 16, "location_summary": "Oakland, California • Aurora, Colorado • New Haven, Connecticut + 12 more", "locations": [ { "city": "Oakland", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "St. Petersburg", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06363760" }, { "nct_id": "NCT04379570", "title": "Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anatomic Stage I Breast Cancer AJCC v8", "Anatomic Stage II Breast Cancer AJCC v8", "Anatomic Stage III Breast Cancer AJCC v8", "HER2 Negative Breast Carcinoma", "Hormone Receptor Positive Breast Carcinoma", "Invasive Breast Carcinoma", "Prognostic Stage I Breast Cancer AJCC v8", "Prognostic Stage II Breast Cancer AJCC v8", "Prognostic Stage III Breast Cancer AJCC v8" ], "interventions": [ { "name": "Educational Intervention", "type": "OTHER" }, { "name": "Text Message-based Navigation Intervention", "type": "OTHER" }, { "name": "Motivational Interviewing", "type": "BEHAVIORAL" }, { "name": "Best Practice", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" } ], "intervention_types": [ "OTHER", "BEHAVIORAL" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 1167, "start_date": "2021-02-15", "completion_date": "2027-10-04", "has_results": false, "last_update_posted_date": "2026-10-19", "last_synced_at": "2026-11-09T22:26:03.735Z", "location_count": 526, "location_summary": "Birmingham, Alabama • Fairbanks, Alaska • Gilbert, Arizona + 406 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fairbanks", "state": "Alaska" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT04379570" }, { "nct_id": "NCT03001323", "title": "Insulin Degludec for the Management of Patient With Recurrent Diabetic Ketoacidosis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes Mellitus" ], "interventions": [ { "name": "Degludec", "type": "DRUG" }, { "name": "Standard long-acting", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hennepin Healthcare Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 27, "start_date": "2017-01", "completion_date": "2020-09-25", "has_results": false, "last_update_posted_date": "2021-05-17", "last_synced_at": "2026-11-09T22:26:03.735Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03001323" }, { "nct_id": "NCT00226759", "title": "Efficacy and Safety of OMS103HP in Patients Undergoing Allograft Anterior Cruciate Ligament (ACL) Reconstruction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Knee Injuries" ], "interventions": [ { "name": "OMS103HP", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Omeros Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "15 Years to 65 Years" }, "enrollment_count": 321, "start_date": "2004-11", "completion_date": "2011-03", "has_results": false, "last_update_posted_date": "2012-10-12", "last_synced_at": "2026-11-09T22:26:03.735Z", "location_count": 18, "location_summary": "Encinitas, California • Redwood City, California • Stanford, California + 15 more", "locations": [ { "city": "Encinitas", "state": "California" }, { "city": "Redwood City", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Englewood", "state": "Colorado" }, { "city": "Steamboat Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00226759" }, { "nct_id": "NCT00879970", "title": "Thiazolidinedione Intervention With Vitamin D Evaluation", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "pioglitazone", "type": "DRUG" }, { "name": "rosiglitazone", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "Vitamin D", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 1332, "start_date": "2009-05", "completion_date": "2010-11", "has_results": true, "last_update_posted_date": "2017-04-18", "last_synced_at": "2026-11-09T22:26:03.735Z", "location_count": 23, "location_summary": "Long Beach, California • Los Angeles, California • Northridge, California + 19 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Decatur", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00879970" } ] }